- Home
- LNTH vs RLI Comparison
LNTH vs RLI Comparison
Compare LNTH & RLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- RLI
- Stock Information
- Founded
- LNTH 1956
- RLI 1965
- Country
- LNTH United States
- RLI United States
- Employees
- LNTH N/A
- RLI N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RLI Property-Casualty Insurers
- Sector
- LNTH Health Care
- RLI Finance
- Exchange
- LNTH Nasdaq
- RLI Nasdaq
- Market Cap
- LNTH 7.5B
- RLI 7.1B
- IPO Year
- LNTH 2015
- RLI 1985
- Fundamental
- Price
- LNTH $79.52
- RLI $74.83
- Analyst Decision
- LNTH Strong Buy
- RLI Hold
- Analyst Count
- LNTH 5
- RLI 8
- Target Price
- LNTH $133.80
- RLI $78.60
- AVG Volume (30 Days)
- LNTH 1.2M
- RLI 399.8K
- Earning Date
- LNTH 05-07-2025
- RLI 04-23-2025
- Dividend Yield
- LNTH N/A
- RLI 6.71%
- EPS Growth
- LNTH N/A
- RLI N/A
- EPS
- LNTH 3.53
- RLI 3.03
- Revenue
- LNTH $1,536,699,000.00
- RLI $1,733,218,000.00
- Revenue This Year
- LNTH $5.81
- RLI N/A
- Revenue Next Year
- LNTH $12.26
- RLI $4.70
- P/E Ratio
- LNTH $22.52
- RLI $24.68
- Revenue Growth
- LNTH 12.53
- RLI 8.88
- 52 Week Low
- LNTH $74.34
- RLI $68.50
- 52 Week High
- LNTH $126.89
- RLI $91.15
- Technical
- Relative Strength Index (RSI)
- LNTH 28.34
- RLI 45.47
- Support Level
- LNTH $78.92
- RLI $73.82
- Resistance Level
- LNTH $108.91
- RLI $75.22
- Average True Range (ATR)
- LNTH 3.92
- RLI 1.54
- MACD
- LNTH -3.09
- RLI -0.01
- Stochastic Oscillator
- LNTH 3.00
- RLI 34.32
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About RLI RLI Corp. (DE)
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.